Longleaf Partners, managed by Southeastern Asset Management, reported a 2.70% return in Q2 2025, compared to Russell 3000’s 10.99% and Russell 2000’s 8.50%. Oscar Health, Inc. (NYSE:OSCR) saw a -3.78% one-month return, closing at $15.27 per share on August 20, 2025, with a market cap of $3.948 billion.

Longleaf Partners noted Oscar Health, Inc. (NYSE:OSCR) as a top contributor, emphasizing its solid operational performance despite market swings due to the Trump bill. They remain optimistic about the company’s long-term potential and management’s strategic approach but trimmed their position during peak sentiment.

Although not among the 30 Most Popular Stocks Among Hedge Funds, 41 hedge fund portfolios held Oscar Health, Inc. (NYSE:OSCR) in Q1 2025. While acknowledging its potential, some AI stocks are seen as offering greater upside with less risk. For more insights on AI stocks and investments, check out the free report on the best short-term AI stock.

Explore high-growth, low-debt stocks including Oscar Health, Inc. (NYSE:OSCR) and gain access to more investor letters from hedge funds and leading investors. Check out articles on the best and worst Dow stocks for the next 12 months, and 10 unstoppable stocks that could double your money for further investment opportunities.

Read more at Yahoo Finance: Longleaf Partners Small-Cap Fund Trimmed Oscar Health (OSCR) on Strength